CytRx Corporation - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for CytRx Corporation. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

CytRx Corporation. The Group's principal activity is developing and commercializing pharmaceutical products. It is involved in the development of novel small molecules based on molecular 'chaperone' co-induction technology, with broad therapeutic applications in neurology, diabetes and cardiology. Products are used for treatment of obesity, type 2 diabetes and human cytomegalovirus.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report